Literature DB >> 11953462

Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57.

Geraldine M A Gillespie1, Rupert Kaul, Tao Dong, Hong-Bing Yang, Tim Rostron, Job J Bwayo, Peter Kiama, Tim Peto, Francis A Plummer, Andrew J McMichael, Sarah L Rowland-Jones.   

Abstract

OBJECTIVES: To determine whether CD8 T lymphocytes from HIV-1-infected patients expressing B*5701 and B*5703 show broad cross-reactivity against different variants of a conserved p24 epitope, which might account for the good prognosis of HIV-1-infected individuals with HLA-B*57.
DESIGN: B*5701+ and B*5703+ were recruited from Nairobi, Kenya and from Oxford, UK. All patients had been HIV positive for at least 8 years and could be categorized as slow progressors.
METHODS: CD8 cytotoxic T cell clones were generated from B*5701+ and B*5703+ donors and tested for their ability to recognize clade variants of an index p24 epitope in standard cytolytic assays. Cross-reactive responses in freshly isolated peripheral blood mononuclear cells (PBMC) were assessed by interferon-gamma (IFNgamma) production and tetramer binding.
RESULTS: Broad cross-clade reactivity for both cytolysis and tetramer binding was observed in CD8 T cell clones from patients harbouring the index epitope sequence. Patterns of cross-reactivity were similar in freshly isolated PBMC but varied between individuals in terms of strength and breath of responses generated. One common variant induced an unusual response with tetramer binding but often failed to induce IFNgamma production, and another was a weak stimulator of both IFNgamma and cytolytic activity.
CONCLUSION: B*5701+ and B5703+ donors demonstrate broad functional cross-reactivity to both common and rare variants of a dominant p24 epitope, which could be relevant to the association of B*57 alleles with slow progression to AIDS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953462     DOI: 10.1097/00002030-200205030-00002

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  53 in total

1.  Long-term control of HIV-1 in hemophiliacs carrying slow-progressing allele HLA-B*5101.

Authors:  Yuka Kawashima; Nozomi Kuse; Hiroyuki Gatanaga; Takuya Naruto; Mamoru Fujiwara; Sachi Dohki; Tomohiro Akahoshi; Katsumi Maenaka; Philip Goulder; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

2.  HLA alleles are associated with altered risk for disease progression and central nervous system impairment of HIV-infected children.

Authors:  Kumud K Singh; Ping Kathryn Gray; Yan Wang; Terence Fenton; Rodney N Trout; Stephen A Spector
Journal:  J Acquir Immune Defic Syndr       Date:  2011-05-01       Impact factor: 3.731

3.  Mhc haplotype H6 is associated with sustained control of SIVmac251 infection in Mauritian cynomolgus macaques.

Authors:  Edward T Mee; Neil Berry; Claire Ham; Ulrike Sauermann; Maria T Maggiorella; Frédéric Martinon; Ernst J Verschoor; Jonathan L Heeney; Roger Le Grand; Fausto Titti; Neil Almond; Nicola J Rose
Journal:  Immunogenetics       Date:  2009-04-01       Impact factor: 2.846

4.  Both HLA-B*57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllers.

Authors:  Camille Lécuroux; Asier Sáez-Cirión; Isabelle Girault; Pierre Versmisse; Faroudy Boufassa; Véronique Avettand-Fenoël; Christine Rouzioux; Laurence Meyer; Gianfranco Pancino; Olivier Lambotte; Martine Sinet; Alain Venet
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

5.  Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects.

Authors:  Shannon R Roff; Missa P Sanou; Mobeen H Rathore; Jay A Levy; Janet K Yamamoto
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape.

Authors:  John T Loffredo; Benjamin J Burwitz; Eva G Rakasz; Sean P Spencer; Jason J Stephany; Juan Pablo Giraldo Vela; Sarah R Martin; Jason Reed; Shari M Piaskowski; Jessica Furlott; Kim L Weisgrau; Denise S Rodrigues; Taeko Soma; Gnankang Napoé; Thomas C Friedrich; Nancy A Wilson; Esper G Kallas; David I Watkins
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

7.  Maintenance or emergence of chronic phase secondary cytotoxic T lymphocyte responses after loss of acute phase immunodominant responses does not protect SIV-infected rhesus macaques from disease progression.

Authors:  M Shannon Keckler; Vida L Hodara; Laura M Parodi; Luis D Giavedoni
Journal:  J Biomed Biotechnol       Date:  2010-05-25

8.  A polymorphism in the HCP5 gene associated with HLA-B*5701 does not restrict HIV-1 in vitro.

Authors:  Woohyun Yoon; Ben-Jiang Ma; Jacques Fellay; Wei Huang; Shi-Mao Xia; Ruijun Zhang; Kevin V Shianna; Hua-Xin Liao; Barton F Haynes; David B Goldstein
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

9.  Enhanced Recognition of HIV-1 Cryptic Epitopes Restricted by HLA Class I Alleles Associated With a Favorable Clinical Outcome.

Authors:  Anju Bansal; Tiffanie Mann; Sarah Sterrett; Binghao J Peng; Anne Bet; Jonathan M Carlson; Paul A Goepfert
Journal:  J Acquir Immune Defic Syndr       Date:  2015-09-01       Impact factor: 3.731

10.  Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1.

Authors:  Jianming Tang; Shenghui Tang; Elena Lobashevsky; Angela D Myracle; Ulgen Fideli; Grace Aldrovandi; Susan Allen; Rosemary Musonda; Richard A Kaslow
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.